Verification evidence is still being completed.
Pharmatory
Oulu, Finland
- Verified lead
- Jaana Karjalainen
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO and Managing Director
- 2026 technical specialization
- CDMO, API Manufacturing, Process R&D, Analytical Services, and cGMP Contract Manufacturing
- Review cycle
- May 2026
- Full address
- Typpitie 1, FI-90620 Oulu, Finland
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official Pharmatory contact page confirming the Oulu visiting address.
- Editorial note
- Pharmatory is published because official company materials confirm current leadership, Oulu operating address, and a real Finnish small-molecule CDMO footprint.
CDMO, API Manufacturing, Process R&D, Analytical Services, and cGMP Contract Manufacturing
Official leadership disclosure, Official Oulu facility disclosure, cGMP and EMA audit disclosure
Pharmatory is published because official company materials confirm current leadership, Oulu operating address, and a real Finnish small-molecule CDMO footprint.
Pharmatory runs small-molecule api manufacturing, process r&d and scale-up, and analytical and regulatory support in Oulu, Finland.
- Lead
- Jaana Karjalainen (verified ↗)
- Address
- Typpitie 1, FI-90620 Oulu, Finland (source ↗)
- Compliance
- cGMP and EMA audit disclosure
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Commercial and development-stage API platform
- Capabilities
- Small-Molecule API Manufacturing · Process R&D and Scale-Up · Analytical and Regulatory Support
- Founded
- 2003
- Headcount
- 11-50
- Company page (open ↗)
Jaana Karjalainen
CEO and Managing Director
Commercial and development-stage API platform
Oulu, Finland. CDMO, API Manufacturing, Process R&D, Analytical Services, and cGMP Contract Manufacturing. Review completed on 22 Mar 2026.
Finnish pharmaceutical manufacturing oversight
Official leadership disclosure, Official Oulu facility disclosure, cGMP and EMA audit disclosure
CDMO, API Manufacturing, Process R&D, Analytical Services, and cGMP Contract Manufacturing
Pharmatory is published because official company materials confirm current leadership, Oulu operating address, and a real Finnish small-molecule CDMO footprint.
Pharmatory is published because official company materials confirm current leadership, Oulu operating address, and a real Finnish small-molecule CDMO footprint.
Core capabilities
Primary declared technical activities and areas of operating focus.
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Declared infrastructure
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Frequently asked questions
- Where is Pharmatory located?
- Pharmatory operates from Typpitie 1, FI-90620 Oulu, Finland, Oulu, Finland.
- Who runs Pharmatory?
- Pharmatory is led by Jaana Karjalainen, CEO and Managing Director. Verified 22 Mar 2026.
- What certifications does Pharmatory hold?
- Pharmatory is documented under cGMP and EMA audit disclosure.
- What does Pharmatory do?
- Pharmatory runs small-molecule api manufacturing, process r&d and scale-up, and analytical and regulatory support in Oulu, Finland. Core capabilities: Small-Molecule API Manufacturing, Process R&D and Scale-Up, Analytical and Regulatory Support.
Related technical briefs
Briefs that name Oulu as a covered market or city.
